Browsing by Autor "Natalia Molina-Moreira"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Thumbnail Image
    Item type: Item ,
    Peril in the market-classification and dosage of species used as anti-diabetics in Lima, Peru
    (BioMed Central, 2013) Rainer W. Bussmann; Narel Y. Paniagua-Zambrana; Marinoli Rivas‐Chamorro; Natalia Molina-Moreira; María Luisa del Rosario Cuadros Negri; J. García
    Our surveys in Mercado Aviación in Lima yielded four species of Gentianella, two of Geranium, and three additional species from three genera used as common additives that were sold as anti-diabetic. These results indicate that even in case of only a few plant species, used for a very clearly circumscribed application, patients run a considerable risk when purchasing their remedies in the market. The possible side effects in this case are the more serious because diabetes has to be treated long term, and as such the patients are ingesting possible toxic remedies over a long period of time. Much more control, and a much more stringent identification of the material sold in public markets, and entering the global supply chain via internet sales, would be needed.